Skip to main content
. 2021 Nov 28;13(23):5989. doi: 10.3390/cancers13235989

Table 4.

Correlation between EpCAM or VIM expression levels in blood CTCs and pathological stage T in NMIBC patients.

EpCAMlow (n = 14/40, 35.0%)
Tis 1/14 (7.1%)
Ta 9/14 (64.3%)
T1 4/14 (28.6%)
EpCAMhigh (n = 26/40, 65.0%)
Tis 2/26 (7.7%)
Ta 22/26 (84.6%)
T1 2/26 (7.7%)
VIMlow (n = 18/40, 45.0%)
Tis 3/18 (16.7%)
Ta 13/18 (72.2%)
T1 2/18 (11.1%)
VIMhigh (n = 22/40, 55.0%)
Ta 18/22 (81.8%)
T1 4/22 (18.2%)